Clinical trial
Impact Of Upadacitinib On The Frequency Of Acute Recurrent Anterior Uveitis In Patients With Axial Spondyloarthritis (UP-FOR-U)
NCT07018206 is registered in ClinicalTrials.gov with CARE ARTHRITIS LTD. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact Of Upadacitinib On The Frequency Of Acute Recurrent Anterior Uveitis In Patients With Axial Spondyloarthritis (UP-FOR-U)
- Lead sponsor
- CARE ARTHRITIS LTD.
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- May 31, 2026
- Completion date
- May 31, 2027
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
axial spondylarthritis (axspa)